Federal Register / Vol. 66, No. 113 / Tuesday, June 12, 2001 / Notices 31649

indicated for that notice or to the offices

of the Board of Governors. Comments

must be received not later than June 26,

2001.

A. Federal Reserve Bank of Kansas

City (D. Michael Manies, Assistant Vice

President) 925 Grand Avenue, Kansas

City, Missouri 64198–0001:

1. Iron Mound Investments, L.L.C.,

Steven C. Davis, Gail Davis, Ernest R.

Davis, Shirley A. Davis, Ricky J. Davis,

Pam Davis, Kenny R. Davis and Gina

Davis, all of Guthrie, Oklahoma, to

acquire voting shares of First National

Bancshares, Inc., Edmond, Oklahoma,

and thereby indirectly acquire voting

shares of First National Bank of

Edmond, Edmond, Oklahoma.

2. Nancy Jones, as Trustee of the

Gwendolyn Jones Irrevocable Trust,

Encino, California; to acquire voting

shares of First Altus Bancorp, Inc.,

Altus, Oklahoma, and thereby indirectly

acquire voting shares of First National

Bank, Altus, Oklahoma.

Board of Governors of the Federal Reserve

System, June 6, 2001.

Robert deV. Frierson

Associate Secretary of the Board.

[FR Doc. 01–14670 Filed 6–11–01; 8:45 am]

BILLING CODE 6210–01–S

FEDERAL RESERVE SYSTEM

Formations of, Acquisitions by, and

Mergers of Bank Holding Companies

The companies listed in this notice

have applied to the Board for approval,

pursuant to the Bank Holding Company

Act of 1956 (12 U.S.C. 1841 et seq.)

(BHC Act), Regulation Y (12 CFR Part

225), and all other applicable statutes

and regulations to become a bank

holding company and/or to acquire the

assets or the ownership of, control of, or

the power to vote shares of a bank or

bank holding company and all of the

banks and nonbanking companies

owned by the bank holding company,

including the companies listed below.

The applications listed below, as well

as other related filings required by the

Board, are available for immediate

inspection at the Federal Reserve Bank

indicated. The application also will be

available for inspection at the offices of

the Board of Governors. Interested

persons may express their views in

writing on the standards enumerated in

the BHC Act (12 U.S.C. 1842(c)). If the

proposal also involves the acquisition of

a nonbanking company, the review also

includes whether the acquisition of the

nonbanking company complies with the

standards in section 4 of the BHC Act

(12 U.S.C. 1843). The nonbanking

activities will be conducted worldwide.

Additional information on all bank

holding companies may be obtained

from the National Information Center

website at www.ffiec.gov/nic/.

Unless otherwise noted, comments

regarding each of these applications

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than July 9, 2001.

A. Federal Reserve Bank of New

York (Betsy Buttrill White, Senior Vice

President) 33 Liberty Street, New York,

New York 10045–0001:

1. Citigroup Inc., New York, New

York; Citigroup Holding Company,

Wilmington, Delaware, and Citicorp,

New York, New York; to acquire 100

percent of the voting shares of Grupo

Financiero Banamex-Accival, S.A., de

C.V., Mexico City, Mexico, and

Banamex USA Bancorp, Los Angeles,

California (‘‘Banamex’’), and thereby

indirectly acquire California Commerce

Bank, Los Angeles, California, and all of

the nonbanking companies of Banamex.

Board of Governors of the Federal Reserve

System, June 6, 2001.

Robert deV. Frierson

Associate Secretary of the Board.

[FR Doc. 01–14669 Filed 6–11–01; 8:45 am]

BILLING CODE 6210–01–S

FEDERAL RESERVE SYSTEM

Meeting; Sunshine Act

AGENCY HOLDING THE MEETING: Board of

Governors of the Federal Reserve

System.

TIME AND DATE: 10:00 a.m., Monday, June

18, 2001.

PLACE: Marriner S. Eccles Federal

Reserve Board Building, 20th and C

Streets, NW., Washington, DC 20551.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

1. Personnel actions (appointments,

promotions, assignments,

reassignments, and salary actions)

involving individual Federal Reserve

System employees.

2. Any items carried forward from a

previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION:

Michelle A. Smith, Assistant to the

Board; 202–452–3204.

SUPPLEMENTARY INFORMATION: You may

call 202–452–3206 beginning at

approximately 5 p.m. two business days

before the meeting for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting; or you may

contact the Board’s Web site at http://

www.federalreserve.gov for an

electronic announcement that not only

lists applications, but also indicates

procedural and other information about

the meeting.

Dated: June 8, 2001.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 01–14925 Filed 6–8–01; 3:01 pm]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 01112]

Clinical Immunization Safety

Assessment Centers (CISA); Notice of

Availability of Funds

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 2001

funds for a cooperative agreement

program for Clinical Immunization

Safety Assessment Centers (CISA). The

term ‘‘Immunization Safety’’

encompasses safety aspects of the

vaccine administration process as well

as the vaccine itself. This program

addresses the following ‘‘Healthy People

2010’’ focus areas of Immunization and

Infectious Diseases, Medical Product

Safety, Public Health Infrastructure,

Maternal, Infant and Child Health,

Health Communication and Access to

Quality Health Services.

The purpose of the program is to

initiate the establishment of a national

network of CISA Centers (hereforth

called Centers) to improve the scientific

understanding of Immunization Safety

issues at the individual patient level.

Because clinically significant adverse

events occur rarely, they are

infrequently seen in clinical trials and

individual clinicians see them too

infrequently to be able to manage them

in a standardized fashion. In

collaboration with CDC, the Centers will

fill this gap by essentially creating a

new medical specialty of Immunization

Safety.

The Centers will develop and

disseminate standardized clinical

evaluation protocols to clinicians who

may be required to apply them to a

patient; they will provide referral and

consultation services to health care

providers on how to evaluate patients

who may have had an adverse reaction

to vaccination, which will include how

to manage the adverse reaction, as well

as advise on continued immunization;

and they will undertake outreach and